Literature DB >> 14080765

IMMUNOLOGICAL AND TOXIC DIFFERENCES BETWEEN MOUSE-VIRULENT AND MOUSE-AVIRULENT CANDIDA ALBICANS.

H D Isenberg, J Allerhand, J I Berkman, D Goldberg.   

Abstract

Isenberg, Henry D. (Long Island Jewish Hospital, New Hyde Park, N.Y.), Jona Allerhand, James I. Berkman, and Dorothy Goldberg. Immunological and toxic differences between mouse-virulent and mouse-avirulent Candida albicans. J. Bacteriol. 86:1010-1018. 1963.-The differences between mouse-avirulent and -virulent strains of Candida albicans reside at least in part in cell surface materials which can be extracted with solvents such as ethanolethyl ether and phenol. These extracts are complex haptens which behave like endotoxins in mice and rabbits. Antibodies produced against intact and extracted cells show some strain specificity in agglutination and precipitin reactions, but underline primarily the differences between the virulent and avirulent variants. The chemical constitution of the extracted complex haptens suggests that the toxic or virulent principles are polysaccharide in nature and that the avirulent strain substitutes fats and lipids for some polysaccharides on their cell surface.

Entities:  

Keywords:  ANTIBODY FORMATION; CANDIDA; CARBOHYDRATE METABOLISM; CHEMISTRY; ENDOTOXINS; EXPERIMENTAL LAB STUDY; HEMAGGLUTINATION; LIPID METABOLISM; MICE; POLYSACCHARIDES; PRECIPITIN TESTS; PROTEIN METABOLISM; RABBITS

Mesh:

Substances:

Year:  1963        PMID: 14080765      PMCID: PMC278559          DOI: 10.1128/jb.86.5.1010-1018.1963

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  Electrophoresis and immunoelectrophoresis of neonatal tears.

Authors:  J ALLERHAND; S KARELITZ; S PENBHARKKUL; A RAMOS; H D ISENBERG
Journal:  J Pediatr       Date:  1963-01       Impact factor: 4.406

2.  Pathogenicity of Candida.

Authors:  S MOURAD; L FRIEDMAN
Journal:  J Bacteriol       Date:  1961-04       Impact factor: 3.490

3.  Serological studies in fungi; comparison of agglutinins and precipitins in anti-candida sera.

Authors:  J JONSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1955

4.  Factors leading to overt monilial disease. I. Preliminary studies of the ecological relationship between Candida albicans and intestinal bacteria.

Authors:  H D ISENBERG; M A PISANO; S L CARITO; J I BERKMAN
Journal:  Antibiot Chemother (Northfield)       Date:  1960-06

5.  Lethality of cell-free extract of Candida albicans for chlortetracycline-treated mice.

Authors:  F J ROTH; W H MURPHY
Journal:  Proc Soc Exp Biol Med       Date:  1957-03

6.  Specific polysaccharides in genus Candida. I. Preparation and properties of water-soluble fractions.

Authors:  J JONSEN; S RASCH; A STRAND
Journal:  Acta Pathol Microbiol Scand       Date:  1955

7.  Endotoxin in pathogenic q fungi.

Authors:  S B SALVIN
Journal:  J Immunol       Date:  1952-07       Impact factor: 5.422

8.  Production in mice of tolerance to the toxic manifestations of Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

9.  Production of tolerance to the toxicity of Candida albicans by nonfungal materials.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

10.  Physicochemical changes in endotoxin associated with loss of biological potency.

Authors:  E RIBI; W T HASKINS; K C MILNER; R L ANACKER; D B RITTER; G GOODE; R J TRAPANI; M LANDY
Journal:  J Bacteriol       Date:  1962-10       Impact factor: 3.490

View more
  4 in total

1.  Biochemical examination of sera during systemic Candida infection in mice.

Authors:  D Oblack; J Schwarz; I A Holder
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  CHARACTERIZATION OF THE PYROGENICITY OF CANDIDA ALBICANS, SACCHAROMYCES CEREVISIAE, AND CRYPTOCOCCUS NEOFORMANS.

Authors:  G S KOBAYASHI; L FRIEDMAN
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

3.  Immunodiagnosis of candida-infections. I. Sensitivity of the antigens.

Authors:  A Tomsíková; J Sach; V Zavázal; L Masler; D Nováckova
Journal:  Mycopathologia       Date:  1980-07-01       Impact factor: 2.574

4.  [Use of a method of lipid extraction from Candida albicans cell walls blastospores. Ultrastructural implications concerning their localization and parietal microfibril organization].

Authors:  D Poulain; G Tronchin; A Vernes
Journal:  Mycopathologia       Date:  1985-12       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.